Long-term prognosis of clinically early IgA nephropathy is not always favorable

Hajeong Lee; Jin Ho Hwang; Jin Ho Paik; Hyun Jin Ryu; Dong-Ki Kim; Ho Jun Chin; Yun Kyu Oh; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee
July 2014
BMC Nephrology;2014, Vol. 15 Issue 1, preceding p1
Academic Journal
Background The long-term prognosis of clinically early IgA nephropathy (IgAN) patients remains to be clarified. We investigated the long-term outcomes of IgAN patients with an apparently benign presentation and evaluated prognostic factors for renal survival. Methods We included patients with biopsy-proven IgAN who had estimated glomerular filtration rates (eGFR) ≥60 mL/min/1.73 m2, normal blood pressure, and proteinuria <0.5 g/day at the time of biopsy. The primary outcome was progression to end-stage renal disease (ESRD). The secondary outcome was a 50% increase in serum creatinine level or an increase in proteinuria to >1 g/day. Results The analysis included 153 patients who met the inclusion criteria. At diagnosis, their median systolic blood pressure was 120 (110-130) mmHg, eGFR was 85.9 (74.9-100.1) mL/min/1.73 m², and proteinuria was 0.25 (0.13-0.38) g/day. Of these, 4 patients died and 6 reached ESRD. The 30-year renal survival rate was 85.5%. Three patients had increased serum creatinine levels and 11 developed proteinuria. Remission was observed in 35 (22.9%) patients. A moderate or severe degree of interstitial fibrosis (adjusted odd ratio [OR] 5.93, 95% confidence interval [CI] 1.44-24.45, P = 0.014) and hypoalbuminemia (adjusted OR 6.18, 95% CI 1.20-31.79, P = 0.029) were independent predictors of the secondary outcome. Conclusions This study showed that the prognosis of early IgAN was not always favorable, even resulting in progression to ESRD in some cases. Hypoalbuminemia and interstitial fibrosis should also be considered important prognostic factors in clinically early IgAN patients.


Related Articles

  • Role of tonsillectomy in the management of IgA nephropathy Mohamed Abd Allah Salama and Wagdy Z. El Badramany.  // Egyptian Journal of Hospital Medicine;Jun2009, Vol. 35, p355 

    Background : The tonsils represent a site of local immunity where immunoglobulin-bearing cells are capable of producing IgA. The tonsils have been considered the foci of abnormal IgA production in IgAN, thus, a relationship is suggested between the tonsillar immune response and the pathogenesis...

  • Steroids in the Treatment of IgA Nephropathy to the Improvement of Renal Survival: A Systematic Review and Meta-Analysis. Yu-Hao Zhou; Li-Gong Tang; Shi-Lei Guo; Zhi-Chao Jin; Mei-Jing Wu; Jia-Jie Zang; Jin-Fang Xu; Chun-Fang Wu; Ying-Yi Qin; Qing Cai; Qing-Bin Gao; Shan-Shan Zhang; Dand-Hui Yu; Jia He // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Background: Studies have shown that steroids can improve kidney survival and decrease the risk of proteinuria in patients with Immunoglobulin A nephropathy, but the overall benefit of steroids in the treatment of Immunoglobulin A nephropathy remains controversial. The aim of this study was to...

  • Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy. Sarcina, Cristina; Tinelli, Carmine; Ferrario, Francesca; Visciano, Bianca; Pani, Antonello; De Silvestri, Annalisa; De Simone, Ilaria; Del Vecchio, Lucia; Terraneo, Veronica; Furiani, Silvia; Santagostino, Gaia; Corghi, Enzo; Pozzi, Claudio // PLoS ONE;7/14/2016, Vol. 11 Issue 7, p1 

    The clinical course of IgA nephropathy (IgAN) and its outcome are extremely variable. Proteinuria at baseline has been considered one of the most important risk factors. More recently, mean proteinuria of follow-up (time-average proteinuria: TAp) was described as a stronger marker of renal...

  • Pulmonary Limited MPO-ANCA Microscopic Polyangiitis and Idiopathic Lung Fibrosis in a Patient with a Diagnosis of IgA Nephropathy. Tilanus, Alwin; Van der Niepen, Patricia; Geers, Caroline; Wissing, Karl Martin // Case Reports in Nephrology;7/22/2015, Vol. 2015, p1 

    We present a case of a male patient with chronic renal insufficiency, due to crescentic glomerulonephritis with IgA deposits, who successively developed (idiopathic) thrombocytopenic purpura (ITP) and MPO-ANCA microscopic polyangiitis (MPA) with pulmonary fibrosis. The patient presented with...

  • Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Wang, Gang; Kwan, Bonnie Ching-Ha; Lai, Fernand Mac-Moune; Chow, Kai-Ming; Li, Philip Kam-Tao; Szeto, Cheuk-Chun // Disease Markers;2011, Vol. 30 Issue 4, p171 

    Background: Previous studies suggested miR-146a and miR-155 play important roles in innate and adaptive immune responses. We studied intra-renal and urinary levels of miR-146a and miR-155 in patients with immunoglobulin A nephropathy (IgAN). Methods: Intra-renal and urinary levels of miR-146a...

  • Restructuring the Ikeda City school urinary screening system: report of a screening survey. Nobuyuki Kajiwara; Kazuyuki Hayashi; Takayuki Fukui; Satoko Yamamoto; Kensuke Senzaki; Shinichiro Murakami; Takuya Kitamura; Takato Ueoka; Mikito Inoue; Shigeki Hayashi; Keiko Sakamoto; Maiko Yoshimoto; Seiko Asano; Ichiro Maki // Asia Pacific Family Medicine;2013, Vol. 12, p6 

    Background: Annual urinary screening is conducted at municipal kindergartens, elementary schools, and junior high schools in Ikeda City, Osaka, Japan (Ikeda City School System), and the results are reviewed by a general physician, but standards for when to recommend specialist referral have not...

  • Microscopic papillary tumor in a renal needle biopsy specimen for IgA nephropathy. Isoshita, Rieko; Usui, Jo-ichi; Uesugi, Noriko; Nagata, Michio; Yamagata, Kunihiro // NDT Plus;Oct2011 Supplement 5, Vol. 4 Issue 5, p357 

    No abstract available.

  • Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial. Gouva, Chariclia; Nikolopoulos, Petros; Ioannidis, John P.A.; Siamopoulos, Kostas C. // Kidney International;Aug2004, Vol. 66 Issue 2, p753 

    Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial. Background. Erythropoietin is known to improve outcomes in patients with anemia from chronic renal disease. However, there is uncertainty about the optimal timing of initiation of...

  • Interrelationship between aortic stiffness and proteinuria in chronic kidney disease. Pan, C. R.; Roos, M.; Schmaderer, C.; Lutz, J.; Wang, J. G.; Heemann, U.; Baumann, M. // Journal of Human Hypertension;Sep2010, Vol. 24 Issue 9, p593 

    Aortic stiffness and proteinuria are cardiovascular risk factors that are generally associated with each other. We analysed whether this is true for patients with chronic kidney disease (CKD). We hypothesized that in CKD patients of young age and predominant sole renal disease, aortic stiffness...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics